Emerging field of metabolic psychiatry suggests that targeting metabolic dysfunction through diet and medications could transform treatment for mental health disorders, shifting focus from managing symptoms to addressing biological drivers.
Metabolic psychiatry is emerging as a way of rethinking some of the most persistent problems in mental health care, with clinicians increasingly examining whether metabolic dysfunction is not merely a side effect of treatment but part of the illness picture itself. In a webinar for the American Psychiatric Association, Shebani Sethi described the field as the study of how metabolic dysfunction, and treatments that target it in the brain and body, affect both psychiatric and metabolic outcomes. The framing places nutrition, inflammation and insulin-related pathways alongside standard psychiatric care rather than outside it.
Sethi argued that the discipline reflects a broader change in clinical thinking. For years, she said, weight gain and insulin resistance were often seen mainly as adverse effects to watch for, rather than as potential therapeutic targets. She told the webinar that insulin signalling in the brain, chronic low-grade inflammation, mitochondrial function and immune responses influenced by diet may sit upstream of psychiatric symptoms, rather than simply following them. That view is helping to shift attention from managing complications to addressing possible biological drivers.
The concept is still relatively new, but it is gathering support from a small body of research. A review on ketogenic metabolic therapy in serious mental illness, published on PubMed Central, argued that insulin resistance and mitochondrial dysfunction may contribute to neural instability and cognitive problems in conditions such as schizophrenia. A separate pilot trial listed on PubMed found that people with bipolar disorder and schizophrenia who followed a ketogenic diet saw improvements in metabolic measures and psychiatric symptoms, suggesting that dietary intervention may have a role alongside medication and psychotherapy.
Related research has also explored low-carbohydrate ketogenic treatment in binge eating and ultraprocessed food addiction, pointing to a possible link between metabolic processes and disordered eating. More recently, a review in Nature examined metabolic psychiatry as an emerging framework across diagnoses, highlighting insulin resistance, lipid imbalance, mitochondrial dysfunction and inflammation as pathways worth targeting. Metabolic Psychiatry Labs, the clinic founded by Sethi, says its model combines dietary change, insulin-sensitising medicines and anti-inflammatory strategies with standard psychiatric treatment, reflecting the field’s aim of treating mind and metabolism together.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
